MentionFox
Home › funding signals › Adialante
Accelerator · announced

Adialante (YC X26) — Cancer screening without barriers

We know how to improve cancer outcomes by 8x-10x: you catch it early. MRI is the most robust and powerful cancer-detection tool in the world, yet systems cost millions to purchase, take months to install, and require high levels of technical skill to operate.

Adialante is a Y Combinator company in the Spring 2026 batch. Its directory entry describes it as: Cancer screening without barriers. The founders listed are Efrain Torres (Founder/CEO), Parker Jenkins (Founder/COO) (Y Combinator directory entry, March 16, 2026).

6 more companies from YC Spring 2026 ↓

Run the free check on Adialante →

Sell to companies like Adialante? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Adialante

New accelerator entry · 2026-03-16 · the record

Spring 2026
batch
4
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchSpring 2026
Announced2026-03-16
StageEarly
StatusActive
Team size4
IndustryHealthcare
Sub-industryHealthcare -> Diagnostics
RegionsUnited States of America, America / Canada, Remote, Partly Remote
BasedSan Francisco, CA, USA
HiringYes
Sitehttp://www.adialante.com
Founded2023
YC group partnerNicolas Dessaigne

Pitching, partnering or investing alongside them? See who really runs and owns Adialante.

Free to see. No signup.

Keep reading

More on Adialante and the records around it.

Also in YC Spring 2026

Same batch, Healthcare first.

What do you want to do with Adialante?

Get the full cited report on Adialante

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Adialante: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

We know how to improve cancer outcomes by 8x-10x: you catch it early. MRI is the most robust and powerful cancer-detection tool in the world, yet systems cost millions to purchase, take months to install, and require high levels of technical skill to operate. We've redesigned MRI from the ground up with new physics, algorithms, and hardware, all to bring cancer screening to the entire world. Our mobile MRI is an imaging clinic on wheels. No equipment to buy, no infrastructure needed. For a flat per-scan fee, any medical site can offer MRI cancer screening. Starting with prostate cancer. Then everything else.

Want the whole picture on Adialante?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Adialante: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Adialante covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Adialante: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Adialante. With no account yet, you sign up free and land on the result.

On these startup lists

Healthcare and health tech startups Biotech startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Adialante: Accepted into Y Combinator Spring 2026
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-adialante
Last updated 2026-11-01
Primary record: Y Combinator directory entry
Adialante (YC X26) — Cancer screening without barriers. MentionFox, 2026-11-01. https://mentionfox.com/funding/yc-adialante